top of page

Blood-Brain Barrier (BBB) Market Key Companies, Business Opportunities, Competitive Landscape

  • elizabethsanchez28
  • Aug 4, 2021
  • 4 min read

The global blood-brain barrier (BBB) market size is expected to reach USD 7.40 Billion in 2028 at a steady CAGR over the forecast period, according to latest analysis by Emergen Research. Major factors driving market revenue growth include major prevalence of neurological disorders such as Parkinson’s Disease, Alzheimer’s Disease, Hunter’s Syndrome, and brain tumors. Other factors include rising healthcare expenses and increasing investment in pharmaceutical research and development. Blood-brain barrier plays a vital role in protecting the brain from toxic compounds and many blood-borne disorders.

To get a PDF sample copy of this report, visit @ https://www.emergenresearch.com/request-sample/633

Competitive Landscape:

The research report offers key insights into the leading market players’ strengths and weaknesses, assessed using Porter’s Five Forces and SWOT analyses. The report includes Blood-Brain Barrier (BBB) market segmentation based on product type, application spectrum, and key regions. The investigative study estimates the market size, market share, and revenue generation over the forecast timeframe. The key players profiled in the report include:

Key players operating in the market are Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.

Some Key Findings From the Report:

· In January 2021, Nanoform Finland signed an agreement with Herantis Pharma. This agreement will help both companies to improve blood-brain-barrier penetration in nasal drug delivery routes for Parkinson’s therapies using nanoparticle technology.

· Parkinson’s disease segment accounted for major revenue share in global market in 2020 and is expected to register a 25.1% CAGR throughout the forecast period. This is attributed to major prevalence of Parkinson’s Disease among an expanding global patient pool.

· Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period, which can be attributed to rapid advancements in pharmaceutical and healthcare infrastructure, increasing aging population, major prevalence of neurological disorders, increasing number of hospitals and long-term care facilities in countries across the globe.

The report categorizes the market into different key segments based on types and applications, along with key regional segmentation. The report offers insights into the segment expected to garner traction during the forecast period, and the region expected to dominate the market in the coming years.

· Application Outlook (Revenue, USD Billion; 2018–2028)

o Alzheimer’s Disease

o Epilepsy

o Parkinson’s Disease

o Multiple Sclerosis

o Hunter’s Syndrome

o Brain Cancer

· Technology Outlook (Revenue, USD Billion; 2018–2028)

o Bispecific Antibody RMT Approach

o Trojan Horse Approach

o Increasing Permeability

o Passive Diffusion

o Others

· End-Use Outlook (Revenue, USD Billion; 2018–2028)

o Hospitals

o Surgical centers

o Research Institutes

o Others

Regional Analysis:

The global Blood-Brain Barrier (BBB) market report broadly considers the market mechanism of both the developing and developed regions of the market. This section provides crucial data and information about the different market regions, a country-wise analysis of the Blood-Brain Barrier (BBB) industry, and an assessment of the market reach and consumer base in the key geographical regions to enable readers to formulate effective business expansion strategies.

Major Geographies Encompassed in the Report:

· North America (U.S., Canada)

· Europe (U.K., Italy, Germany, France, Rest of EU)

· Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

· Latin America (Chile, Brazil, Argentina, Rest of Latin America)

· Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a customized copy of the report @ https://www.emergenresearch.com/request-for-customization/633

Objectives of the Global Blood-Brain Barrier (BBB) Market Study:

· An in-depth study of the evolving market sectors and the growth & penetration status of the global Blood-Brain Barrier (BBB) market

· COVID-19 Impact Analysis to highlight the major opportunities and challenges

· Strategic recommendations to help readers formulate lucrative business strategies

· Identification of the emerging players and their tactical approaches to expand market presence

· An extensive study of the product portfolios of the major market players and their regional presence

· A closer look at the strategic initiatives undertaken by the leading companies across this industry, including mergers & acquisitions, collaborations, partnerships, and joint ventures

Table of Content:

Chapter 1. Methodology & Sources 1.1. Market Definition 1.2. Research Scope 1.3. Methodology 1.4. Research Sources 1.4.1. Primary 1.4.2. Secondary 1.4.3. Paid Sources 1.5. Market Estimation Technique Chapter 2. Executive Summary 2.1. Summary Snapshot, 2018-2028 Chapter 3. Key Insights Chapter 4. Global Blood-Brain Barrier (BBB) Market Segmentation & Impact Analysis 4.1. Global Blood-Brain Barrier (BBB) Market Segmentation Analysis 4.2. Industrial Outlook 4.2.1. Market indicators analysis 4.2.2. Market drivers analysis 4.2.2.1. Growing geriatric population. 4.2.2.2. Rising incidences of neurological diseases. 4.2.3. Market restraints analysis 4.2.3.1. Risk of leakage in blood-brain barrier 4.2.3.2. High cost of treatment 4.3. Technological Insights 4.4. Regulatory Framework 4.5. Porter’s Five Forces Analysis 4.6. Competitive Metric Space Analysis 4.7. Price trend Analysis 4.8. Covid-19 Impact Analysis

Chapter 5. Global Blood-Brain Barrier (BBB) Market Application Insights & Trends, Revenue (USD Billion) 5.1. Application Dynamics & Market Share, 2018 & 2028 5.1.1. Alzheimer’s Disease 5.1.2. Epilepsy 5.1.3. Parkinson’s Disease 5.1.4. Multiple Sclerosis 5.1.5. Hunter’s Syndrome 5.1.6. Brain Cancer

READ MORE…!

For further details on this report, click here @ https://www.emergenresearch.com/industry-report/blood-brain-barrier-market

Thank you for reading our report. For further details or to inquire about customization, please let us know. We will offer you the report as per your needs.

Read similar reports by Emergen Research:

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

 
 
 

Recent Posts

See All

Comments


Post: Blog2_Post

Subscribe Form

Thanks for submitting!

  • Facebook
  • Twitter
  • LinkedIn

©2020 by Stumble Data Insights. Proudly created with Wix.com

bottom of page